Relapsing multiple sclerosis (RMS) is the most common form of multiple sclerosis. Since there is no cure, patients are maintained on disease-modifying therapy (DMT) to help slow disease progression, reduce disease relapses, ...
Aug 1, 2022
0
2
Patients with multiple sclerosis (MS) treated with the drug rituximab had a significantly lower risk of relapse compared with MS patients receiving standard treatment. This has been shown in a phase 3 clinical trial by researchers ...
Jul 13, 2022
0
64
An international research team coordinated by Dr. Oscar Molina and Dr. Pablo Menéndez, from the Josep Carreras Leukaemia Research Institute, identifies chromosomal abnormalities associated with relapse in a frequent subset ...
Jul 7, 2022
0
16
Artificial intelligence (AI) may be able to identify alcoholics at risk of relapsing after treatment, researchers say.
Apr 19, 2022
0
3
Some Latino children diagnosed with acute lymphoblastic leukemia (ALL) were more likely to experience relapse than non-Hispanic white children, according to data presented at the AACR Annual Meeting 2022, held April 8-13. ...
Apr 12, 2022
0
5
Researchers developing treatments for addiction are turning to virtual reality and gaming to help patients overcome their lack of impulse control and decrease the relapse rates.
Mar 29, 2022
0
3
New research shows that Mindfulness-Based Cognitive Therapy (MBCT) can help promote self-kindness in people with a history of depression, thereby putting their bodies in a state of safety and relaxation.
Mar 9, 2022
0
29
Almost all family intervention models can prevent relapse in schizophrenia, according to a systematic review and meta-analysis published in the March issue of The Lancet Psychiatry.
Feb 24, 2022
0
20
A new study has revealed detailed information on the various ways patients with multiple sclerosis (MS) become disabled, analyzing both the role of relapses on long-term outcomes and the role of worsening that occurs independent ...
Feb 14, 2022
0
14
MS relapses of clinical relevance are known to occur in up to 80 percent of patients within four to seven months of stopping natalizumab. It is also a known fact that pregnancy has a mitigating effect on the disease. To find ...
Feb 4, 2022
0
11
